Stage-specific treatment costs for cervical cancer in the United Kingdom
Wolstenholme JL., Whynes DK.
In order to examine the relationship between stage at initial diagnosis and management costs for cervical cancer, a detailed cost audit over 5 years was conducted on a sample of patients diagnosed in 1990 in one U.K. region. The mean costs of managing pre-invasive carcinoma ((L)386) were found to be significantly lower than those of stage 1 invasive carcinoma ((L)6623) and both were lower than the costs of invasive cancer at stages 2-4 ((L)10910, (L)10579 and (L)11035, respectively). A comparison of management costs for cervical cancer with those of breast cancer by stage revealed both that the former are invariably higher and that the cost-by-stage profiles for the two diseases are dissimilar.